Rate the Article: Trogocytosis and Acquired PD1 Receptor in Leukemia & Its Role in Cancer Immunology, IJSR, Call for Papers, Online Journal
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064

Downloads: 24 | Views: 465 | Weekly Hits: ⮙2 | Monthly Hits: ⮙2

Review Papers | Cancer Science | India | Volume 12 Issue 7, July 2023 | Rating: 6.6 / 10


Trogocytosis and Acquired PD1 Receptor in Leukemia & Its Role in Cancer Immunology

Achyusman Samanta, Amrita Tiwari


Abstract: Aim: Cancer, one of the most dreaded diseases of human beings, has always been the cynosure of researchers. Everyday, new studies are being done to know more about the tumor cell - immune cell interactions that further lead to a generation of new techniques and therapies for cancer treatment. Method: The phenomenon that has catched everyone?s eye is trogocytosis. The discovery of this unusual transfer mechanism has apprised the interest of oncologists and immunologists in cancer immunotherapy. Our study will focus on leukemia among other cancers. We will also analyze the role of ligand - receptor engagements and signaling pathways. Conclusion: In conclusion, we will review the role of trogocytosis in cancer immunology, how it inhibits immune cell responses, and its significance in non - immunological processes.


Keywords: Leukemia, Trogocytosis, PD - 1, pMHC, Fc? receptor, PI3K - AKT pathway


Edition: Volume 12 Issue 7, July 2023,


Pages: 1763 - 1766



Rate this Article


Select Rating (Lowest: 1, Highest: 10)

5

Your Comments (Only high quality comments will be accepted.)

Characters: 0

Your Full Name:


Your Valid Email Address:


Type This Verification Code Below: 9042


Top